We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AGNTF market cap is 0. The company's latest EPS is AUD -0.0483 and P/E is -12.63.
| Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 0 | 0 | 296k | 259k | 1.75M |
| Operating Income | -383k | 0 | -614k | -4.09M | -4.88M |
| Net Income | -383k | 0 | -1.03M | -4.09M | -4.82M |
| Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 378k | 7.52M | 7.27M | 9.04M | 9.54M |
| Total Liabilities | 359k | 58k | 426k | 736k | 1.88M |
| Total Equity | 19k | 7.46M | 6.85M | 8.31M | 7.67M |
| Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -59k | N/A | -1.05M | -3.36M | -3.3M |
| Investing | N/A | N/A | N/A | N/A | -50k |
| Financing | 401k | N/A | 7.85M | 5.13M | 3.73M |
| Market Cap | 0 |
| Price to Earnings Ratio | -12.63 |
| Price to Sales Ratio | 34.86 |
| Price to Cash Ratio | 6.55 |
| Price to Book Ratio | 7.94 |
| Dividend Yield | - |
| Shares Outstanding | 99.74M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Argenica Therapeutics Ltd (PK) |
| Address |
unit 4 nedlands, western australia 6009 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
